Federica Quirini

655 total citations
17 papers, 432 citations indexed

About

Federica Quirini is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Federica Quirini has authored 17 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 6 papers in Oncology. Recurrent topics in Federica Quirini's work include Lymphoma Diagnosis and Treatment (15 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Federica Quirini is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Federica Quirini collaborates with scholars based in Italy, Australia and United States. Federica Quirini's co-authors include Vittorio Stefoni, Lisa Argnani, Pier Luigi Zinzani, Alessandro Broccoli, Cinzia Pellegrini, Enrico Derenzini, Michele Baccarani, Stefano Pileri, Letizia Gandolfi and L Gandolfi and has published in prestigious journals such as Blood, Cancer and Annals of Oncology.

In The Last Decade

Federica Quirini

17 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federica Quirini Italy 11 372 179 116 115 87 17 432
Letizia Gandolfi Italy 13 413 1.1× 196 1.1× 150 1.3× 66 0.6× 35 0.4× 28 504
Manuel F. Rosado United States 10 333 0.9× 249 1.4× 97 0.8× 87 0.8× 67 0.8× 14 491
Keenan Fenton United States 11 531 1.4× 434 2.4× 91 0.8× 128 1.1× 110 1.3× 33 648
B Coiffier France 7 392 1.1× 233 1.3× 267 2.3× 168 1.5× 55 0.6× 13 519
Marjan Ertault France 9 222 0.6× 88 0.5× 84 0.7× 51 0.4× 52 0.6× 14 306
Taoufik El Gnaoui France 7 341 0.9× 226 1.3× 120 1.0× 40 0.3× 40 0.5× 17 388
M. Bast United States 8 558 1.5× 347 1.9× 200 1.7× 65 0.6× 37 0.4× 10 609
Catherine Chassagne‐Clément France 13 282 0.8× 145 0.8× 119 1.0× 43 0.4× 30 0.3× 44 410
Ana Ayala United States 9 381 1.0× 270 1.5× 196 1.7× 64 0.6× 19 0.2× 16 474
Ken Ohmachi Japan 13 403 1.1× 342 1.9× 211 1.8× 91 0.8× 42 0.5× 46 599

Countries citing papers authored by Federica Quirini

Since Specialization
Citations

This map shows the geographic impact of Federica Quirini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federica Quirini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federica Quirini more than expected).

Fields of papers citing papers by Federica Quirini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federica Quirini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federica Quirini. The network helps show where Federica Quirini may publish in the future.

Co-authorship network of co-authors of Federica Quirini

This figure shows the co-authorship network connecting the top 25 collaborators of Federica Quirini. A scholar is included among the top collaborators of Federica Quirini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federica Quirini. Federica Quirini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Broccoli, Alessandro, Beatrice Casadei, Vittorio Stefoni, et al.. (2017). The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients. BMC Cancer. 17(1). 276–276. 10 indexed citations
2.
3.
Derenzini, Enrico, Vittorio Stefoni, Cinzia Pellegrini, et al.. (2015). High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience. BMC Cancer. 15(1). 879–879. 10 indexed citations
4.
Zinzani, Pier Luigi, Letizia Gandolfi, Beatrice Casadei, et al.. (2015). Long-Term Responders after Brentuximab Vedotin: Experience on 57 Patients with Relapsed and Refractory Hodgkin and Anaplastic Large Cell Lymphoma. Blood. 126(23). 2725–2725. 1 indexed citations
5.
Pellegrini, Cinzia, Alessandro Broccoli, Beatrice Casadei, et al.. (2015). Phase II Study of the Fondazione Italiana Linfomi on Gemcitabine Plus Romidepsin (GEMRO Regimen) in Relapsed and Refractory Peripheral T-Cell Lymphoma Patients. Blood. 126(23). 3937–3937. 2 indexed citations
6.
Zinzani, Pier Luigi, Cinzia Pellegrini, Beatrice Casadei, et al.. (2013). Primary Mediastinal Large B-Cell Lymphoma: Investigation On The Role Of Rituximab and PET During Treatment. Blood. 122(21). 3046–3046. 2 indexed citations
7.
Zinzani, Pier Luigi, Cinzia Pellegrini, Letizia Gandolfi, et al.. (2012). Extranodal marginal zone B‐cell lymphoma of the lung: experience with fludarabine and mitoxantrone‐containing regimens. Hematological Oncology. 31(4). 183–188. 23 indexed citations
8.
Pellegrini, Cinzia, Beatrice Casadei, Enrico Derenzini, et al.. (2012). The Role of Interim-PET and Final-PET in the Outcome of Peripheral T-Cell Lymphoma (PTCL) Treated At the Diagnosis with CHOP.. Blood. 120(21). 2721–2721. 4 indexed citations
9.
Zinzani, Pier Luigi, Cinzia Pellegrini, Emanuela Merla, et al.. (2012). Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study. Hematological Oncology. 31(4). 179–182. 14 indexed citations
10.
Zinzani, Pier Luigi, Monica Tani, Alessandro Pulsoni, et al.. (2011). A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by 90Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma. Annals of Oncology. 23(2). 415–420. 20 indexed citations
11.
Zinzani, Pier Luigi, Cinzia Pellegrini, Letizia Gandolfi, et al.. (2011). Combination of Lenalidomide and Rituximab in Elderly Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Phase 2 Trial. Clinical Lymphoma Myeloma & Leukemia. 11(6). 462–466. 91 indexed citations
12.
Pellegrini, Cinzia, Letizia Gandolfi, Federica Quirini, et al.. (2011). Primary Bone Lymphoma: Evaluation of Chemoimmunotherapy as Front-line Treatment in 21 Patients. Clinical Lymphoma Myeloma & Leukemia. 11(4). 321–325. 24 indexed citations
13.
Zinzani, Pier Luigi, Cinzia Pellegrini, Vittorio Stefoni, et al.. (2010). Hairy cell leukemia. Cancer. 116(20). 4788–4792. 38 indexed citations
14.
Zinzani, Pier Luigi, Letizia Gandolfi, Alessandro Broccoli, et al.. (2010). Midtreatment 18F‐fluorodeoxyglucose positron‐emission tomography in aggressive non‐Hodgkin lymphoma. Cancer. 117(5). 1010–1018. 49 indexed citations
15.
Zinzani, Pier Luigi, Luigi Rigacci, Vittorio Stefoni, et al.. (2010). Early Interim 18f-FDG PET In Hodgkin's Lymphoma: Evaluation on 304 Patients. Blood. 116(21). 3879–3879. 1 indexed citations
16.
Zinzani, Pier Luigi, Filippo Venturini, Vittorio Stefoni, et al.. (2009). Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome. Annals of Oncology. 21(4). 860–863. 126 indexed citations
17.
Stefoni, Vittorio, Alessandro Broccoli, Lapo Alinari, et al.. (2009). Predictive role of Early Interim FDG-PET in Hodgkin Lymphoma.. Blood. 114(22). 1659–1659. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Letizia Gandolfi Breakdown of academic impact, for papers by Manuel F. Rosado Breakdown of academic impact, for papers by Keenan Fenton Breakdown of academic impact, for papers by B Coiffier Breakdown of academic impact, for papers by Marjan Ertault Breakdown of academic impact, for papers by Taoufik El Gnaoui Breakdown of academic impact, for papers by M. Bast Breakdown of academic impact, for papers by Catherine Chassagne‐Clément Breakdown of academic impact, for papers by Ana Ayala Breakdown of academic impact, for papers by Ken Ohmachi
Rankless by CCL
2026